Login / Signup

Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers.

Elizabeth A SpencerJami KinnucanJulie WangMarla C Dubinsky
Published in: Crohn's & colitis 360 (2020)
In this large, real-world study of acute infusion reactions to ustekinumab, the rate was similar to that seen in clinical trials-0.8%-3%.
Keyphrases
  • liver failure
  • tertiary care
  • clinical trial
  • respiratory failure
  • low dose
  • drug induced
  • aortic dissection
  • hepatitis b virus
  • randomized controlled trial
  • extracorporeal membrane oxygenation
  • mechanical ventilation